Bank of America Corporation »

Eupraxia Pharmaceuticals shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 268k 7.24

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Affinity Asset Advisors
Balyasny Asset Management
Vivo Capital
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Partner Fund Management
Ameriprise Financial

View all funds holding Eupraxia Pharmaceuticals